Approved by the Board on: 17 January 2025
The Board acknowledges that:
Therefore, the Board:
Budgetary implications (included in, or additional to, OPEX budget): Incremental management and operating costs directly attributable to C19RM will increase by 0.5% (from 4.5% to 5%).